Correct, it is old news. Share price digested it long ago.
Since then, trial news has been really positive across the board and Immutep has largely de-risked since the Fast Track ann with Keytruda.
I don’t know about sky rocketing just yet( positive results are expected and won’t surprise the market) but the company remains good value(imo) with a solid upward share price trend showing good rising support levels over an extended period, including a large capital raise.
At some point the share price will re-rate over the next 12 months, that’s my opinion. Whether that happens steadily or in a sky rocket is anyone’s guess.
Correct, it is old news. Share price digested it long ago.Since...
-
- There are more pages in this discussion • 431 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $598.3M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 41.0¢ | $1.132M | 2.721M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15565 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 246989 | 7 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |